Data protection Impressum

Life sciences

Western Switzerland medtech start-ups ORamaVR and Compremium are progressing toward clinical validation of their technologies, targeting major improvements in surgical training and cancer diagnostics.

ORamaVR and Compremium unveil new tools for surgical training and diagnosis

2 July 2025

Adiposs secures CHF 4 million to advance ImageBAT, a novel contrast agent using CT scans to predict cancer treatment response via brown fat imaging.

Adiposs raises CHF 4 million to advance brown fat imaging in cancer care

1 July 2025

ADM is strengthening its innovation footprint in Western Switzerland with a new R&D center focused on microbiomes to support animal health. The center is located at the Biopôle in Lausanne.

ADM opens new R&D center at Biopôle to advance animal microbiome science

30 June 2025

Superlab Suisse will open a new laboratory at Campus Biotech in Geneva in January 2026, strengthening the region’s innovation infrastructure for life sciences start-ups.

Superlab expands to Geneva with new lab at Campus Biotech

25 June 2025

Launched in Hamburg, the ORYL F1 marks a new milestone for EPFL spin-off ORYL Photonics, combining speed, precision, and sustainability for drug development.

ORYL Photonics launches breakthrough solubility and aggregation measurement platform

24 June 2025

Backed by public funding and growing clinical interest, AirScale's sensor-based technology aims to simplify hospital workflows and improve patient care.

Bern-based medtech AirScale develops smart weighing solution for immobile patients

23 June 2025

Biotech KYLYS Aesthetics has raised CHF 1 million to advance clinical development of its next-generation hyaluronic acid medical devices for regenerative aesthetic medicine.

Geneva-based KYLYS raises CHF 1 million to advance regenerative aesthetic medicine

23 June 2025

The Lausanne University Hospital (CHUV) strengthens its oncology network with the launch of a dedicated bladder cancer center offering personalized, high-level treatment and coordinated support.

CHUV opens new bladder cancer center combining advanced care and interdisciplinary expertise

16 June 2025

Hedera Dx has secured EUR 15 million to expand hospital-based cancer diagnostics, making precision oncology more accessible to patients worldwide.

Hedera Dx raises EUR 15 million to expand access to precision cancer care

27 May 2025

Geneva-based Syrhatech has raised CHF 4.5 million to expand its R&D and manufacturing of injectable hyaluronic acid-based medical devices to support growing demand in dermatology, orthopedics, and ophthalmology.

Syrhatech raises CHF 4.5 million to innovate in hyaluronic acid medical devices

27 May 2025

1 2 3 4 5 6 … 43